Prof. Steven A. Soper
Prof. Steven A. Soper presented a talk August 20, 2018 at the Next Generation Dx Summit in Washington, DC. His talk was titled, “New Tools for Liquid Biopsies: Microfluidics for the Efficient Isolation of Circulating Leukemia and Myeloma Cells.” In his talk, he discussed his group’s work in negating the need for bone marrow biopsies by using liquid biopsies for leukemia and multiple myeloma by selecting circulating cells from whole blood to manage these diseases. Acute myeloid leukemia (AML) and pediatric acute lymphoblastic leukemia (ALL) minimum residual disease states were monitored for signs of recurrence using circulating leukemia cells. For multiple myeloma, circulating cells were used to stage patients (MGUS, smoldering or active myeloma).
See the Next Generation Dx Summit website for the complete conference schedule.